HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Paul J Kurtin Selected Research

Carboxypeptidases A (Carboxypeptidase A)

1/2020Carboxypeptidase A1 and regenerating islet-derived 1α as new markers for pancreatic acinar cell carcinoma.
10/2019Paraneoplastic Cast Nephropathy Associated With Pancreatic Mixed Acinar-Neuroendocrine Carcinoma: A Case Report.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Paul J Kurtin Research Topics

Disease

25Amyloidosis
09/2022 - 02/2004
17Neoplasms (Cancer)
01/2020 - 11/2002
13Amyloid Plaque
09/2022 - 03/2014
11Lymphoma (Lymphomas)
01/2022 - 06/2002
9Non-Hodgkin Lymphoma (Lymphosarcoma)
11/2018 - 01/2002
5Familial Amyloidosis (Hereditary Amyloidosis)
11/2018 - 05/2014
4Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
04/2011 - 07/2004
3B-Cell Lymphoma (Lymphoma, B Cell)
01/2020 - 01/2002
3Immunoglobulin Light-chain Amyloidosis
01/2019 - 03/2014
3Glomerulonephritis
01/2017 - 05/2015
3Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
10/2011 - 06/2006
3Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
01/2009 - 07/2002
2Multiple Myeloma
10/2019 - 02/2007
2Carcinoma (Carcinomatosis)
10/2019 - 02/2005
2Transthyretin-Related Hereditary Amyloidosis
08/2017 - 07/2014
2Disease Progression
08/2017 - 02/2007
2Chronic Renal Insufficiency
01/2017 - 01/2016
2Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II)
01/2017 - 06/2016
2Autoimmune Diseases (Autoimmune Disease)
06/2016 - 11/2005
2Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
01/2016 - 08/2006
2B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
05/2015 - 11/2002
2Thrombocytopenia (Thrombopenia)
04/2011 - 08/2008
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
03/2011 - 04/2003
2T-Cell Lymphoma (Lymphoma, T Cell)
08/2008 - 08/2006
1Hodgkin Disease (Hodgkin's Disease)
01/2022
1Deafness (Deaf Mutism)
09/2020
1Sensorineural Hearing Loss
09/2020
1Stroke (Strokes)
01/2020
1Cardiac Arrhythmias (Arrythmia)
01/2020
1Atrial Fibrillation
01/2020
1Acinar Cell Carcinoma
01/2020
1Acute Kidney Injury (Acute Renal Failure)
10/2019
1Sepsis (Septicemia)
10/2019
1Heart Failure
11/2018
1Peripheral Nervous System Diseases (PNS Diseases)
11/2018
1Eosinophilia
10/2018
1Systemic Mastocytosis
10/2018
1Pdgfra-Associated Chronic Eosinophilic Leukemia
10/2018
1Hypereosinophilic Syndrome (Loeffler Endocarditis)
10/2018
1Adenocarcinoma
02/2018

Drug/Important Bio-Agent (IBA)

19Amyloid (Amyloid Fibrils)IBA
09/2022 - 02/2004
12Proteins (Proteins, Gene)FDA Link
03/2022 - 06/2006
11Congo RedIBA
03/2022 - 01/2013
9Rituximab (Mabthera)FDA Link
10/2017 - 01/2002
9ParaffinIBA
04/2015 - 01/2002
7Peptides (Polypeptides)IBA
08/2017 - 05/2014
5Immunoglobulins (Immunoglobulin)IBA
10/2019 - 07/2014
3Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA
10/2019 - 07/2014
3GelsolinIBA
11/2018 - 01/2013
3Chemotactic FactorsIBA
02/2017 - 03/2014
3Biological ProductsIBA
08/2009 - 02/2007
3AntigensIBA
04/2005 - 09/2002
3AntibodiesIBA
04/2005 - 01/2002
2Biomarkers (Surrogate Marker)IBA
01/2022 - 10/2008
2Carboxypeptidases A (Carboxypeptidase A)IBA
01/2020 - 10/2019
2AA amyloidosisIBA
10/2019 - 04/2016
2IgKIBA
11/2018 - 12/2006
2Mutant Proteins (Protein, Mutant)IBA
11/2018 - 09/2018
2Pharmaceutical PreparationsIBA
10/2018 - 08/2008
2Apolipoprotein C-II (ApoC2)IBA
09/2018 - 02/2017
2Dexamethasone (Maxidex)FDA LinkGeneric
10/2017 - 10/2011
2Cytarabine (Cytosar-U)FDA LinkGeneric
10/2017 - 10/2011
2PlatinumIBA
10/2017 - 06/2008
2Complement System Proteins (Complement)IBA
01/2017 - 06/2016
2apolipoprotein A-IV (apolipoprotein AIV)IBA
01/2017 - 01/2016
2ParaproteinsIBA
06/2016 - 06/2009
2ApolipoproteinsIBA
01/2016 - 01/2013
2Immunoglobulin M (IgM)IBA
05/2015 - 04/2003
2Immunoglobulin G (IgG)IBA
05/2015 - 06/2009
2Formaldehyde (Formol)FDA Link
04/2015 - 05/2014
2ProteomeIBA
07/2014 - 05/2014
2Doxorubicin (Adriamycin)FDA LinkGeneric
10/2011 - 10/2011
2Vincristine (Oncovin)FDA LinkGeneric
10/2011 - 10/2011
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
10/2011 - 10/2011
2temsirolimusFDA Link
04/2011 - 08/2008
2TOR Serine-Threonine KinasesIBA
04/2011 - 08/2008
2CytokinesIBA
07/2007 - 11/2005
2Interleukin-12 (IL 12)IBA
10/2006 - 01/2002
2ChemokinesIBA
08/2006 - 11/2002
2ClusterinIBA
02/2005 - 08/2004
1Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
03/2022
1Lymphoid Enhancer-Binding Factor 1IBA
01/2022
1CateninsIBA
01/2022
1Extracellular Matrix ProteinsIBA
02/2021
1Epidermal Growth Factor (EGF)IBA
02/2021
1fibulinIBA
02/2021
1EnzymesIBA
01/2020
1Adenosine Monophosphate (AMP)IBA
01/2020
1AnthracyclinesIBA
11/2018
1Prealbumin (Transthyretin)IBA
11/2018
1Tryptases (Tryptase)IBA
10/2018
1Diflunisal (Dolobid)FDA Link
10/2018
1Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA
10/2018
1Periodic AcidIBA
09/2018
1Oxaliplatin (Eloxatin)FDA LinkGeneric
10/2017

Therapy/Procedure

7Drug Therapy (Chemotherapy)
10/2019 - 02/2004
6Lasers (Laser)
10/2019 - 01/2013
6Therapeutics
01/2016 - 04/2003
2Radiotherapy
10/2019 - 10/2011
1Maze Procedure
01/2020